Other
TNF blockers
Tumor necrosis factor (TNF) blocking agent, biologic
Other names: adalimumab, Humira, Hadlima, adalimumab-bwwd, etanercept, Enbrel
Wait
2 weeks
ground trial when starting
Different waits apply in other cases.
Examiner
The examiner can issue when the document's criteria are met
FAA label
ACCEPTABLE
The FAA lists adalimumab, certolizumab, etanercept and golimumab as acceptable biologics when the underlying condition qualifies, with a two-week ground trial when starting and four hours of no-fly after each dose; FDA-approved biosimilars count the same.
Track your medicationsMore detail: TNF blockersThe rest of Crosscheck's reading, in plain wordsOpen
Wait
- 4 hours no-fly after each dose
- a forty-eight hour ground trial when changing from one biologic or biosimilar to another for the same indication
Changing from one biologic or biosimilar to another for the same indication requires a 48-hour ground trial.
- 14 days after starting: ground observation
- 4 hours after each dose: no flying
Show the FAA's words: TNF blockersThe official FAA wording: two passages, each with its document and dateOpen
Initial observation: All require a 2-week no-fly/ground trial to verify no side effects.
ACCEPTABLE BIOLOGICS - MONOTHERAPY MEDICATION Permitted if the underlying condition qualifies; consult the condition pages for details.
Tumor Necrosis Factor (TNF) Blocking Agent: adalimumab (Humira), certolizumab (Cimzia), etanercept (Enbrel), golimumab (Simponi), 4 hours
FDA-approved biosimilars are also acceptable for any referenced brand name medication (e.g., Hadlima [adalimumab-bwwd] for Humira [adalimumab]).
Changing from one biologic/biosimilar to another for the same indication requires a forty-eight (48) hour ground trial to mitigate any aeromedical risk.